Breast Cancer
Conference Coverage
Circulating tumor DNA may predict poor prognosis in breast cancer
Detection of ctDNA at any time point was associated with worse overall and disease-free survival in early breast cancer patients.
Conference Coverage
Breast cancer survivors need a comprehensive care plan, says doctor
Survivor care for cancer patients should address physical and psychological symptoms through an integrated model, expert says.
Conference Coverage
Genomic assay changes minds on HER2+ BC treatment
In a small study, 56% of oncologists revised plans after getting results of HER2DX tests.
Conference Coverage
Atezolizumab is associated with enhanced response in triple-negative breast cancer
The addition of atezolizumab to chemotherapy yielded higher pCR than chemotherapy alone.
From the Journals
Risk for breast cancer reduced after bariatric surgery
“The importance of this study is that it shows that weight loss in midlife can reduce breast cancer risk back to or even below the risk of similar...
Conference Coverage
BMI has greater impact on survival in younger breast cancer patients
Study of women on endocrine therapy for breast cancer addresses the effects of BMI on survival.
From the Journals
Number of cancer survivors with functional limitations doubled in 20 years
The 70% prevalence of functional limitation among survivors in 2018 is nearly twice that of the general population.
News from the FDA/CDC
New USPSTF draft suggests mammography start at 40, not 50
“It is now clear that screening every other year starting at age 40 has the potential to save about 20% more lives among all women.”
From the Journals
Familial cancer risk complex, not limited to same site
“The findings suggest that the familial risk extends to discordant early-onset cancers, including ovarian, testicular, and pancreatic cancers, as...
From the Journals
Pausing endocrine therapy to attempt pregnancy is safe
The results provide the “strongest evidence to date on the short-term safety of this choice.”
Conference Coverage
Mammography after breast cancer: No benefit for older patients?
“Ongoing surveillance mammography in these patients may lead to overdiagnosis and overtreatment of cancers that potentially would not harm...